We are live on ! Find out more
SCM

Suffolk Capital Management Portfolio holdings

AUM $521M
1-Year Est. Return 9.79%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
-9.79%
3 Year Est. Return
+48.57%
5 Year Est. Return
+94.78%
10 Year Est. Return
AUM
$827M
AUM Growth
+$20.2M
Cap. Flow
-$13.6M
Cap. Flow %
-1.65%
Top 10 Hldgs %
20.22%
Holding
168
New
33
Increased
41
Reduced
59
Closed
29

Top Sells

Rank Stock Value
1
ALTR
Altera Corp
ALTR
+$12.7M
2
HBI
Hanesbrands
HBI
+$12.6M
3
AVGO icon
Broadcom
AVGO
+$12.4M
4
OMC icon
Omnicom Group
OMC
+$12.4M
5
RL icon
Ralph Lauren
RL
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Industrials 17.61%
3 Healthcare 14.82%
4 Communication Services 11.85%
5 Consumer Discretionary 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAH
26
DELISTED
JARDEN CORPORATION
JAH
$11.7M 1.42%
+296,280
New +$11.3M
WHR icon
27
Whirlpool
WHR
$2.49B
$11.5M 1.39%
82,675
+3,285
+4% +$482K
PCP
28
DELISTED
PRECISION CASTPARTS CORP
PCP
$11.4M 1.38%
45,230
-200
-0.4% -$51.1K
ETN icon
29
Eaton
ETN
$150B
$11.4M 1.38%
147,877
+5,360
+4% +$398K
PVH icon
30
PVH
PVH
$4.01B
$11.4M 1.38%
+97,584
New +$12.1M
VTRS icon
31
Viatris
VTRS
$20.8B
$11.2M 1.35%
216,648
-29,302
-12% -$1.44M
PNR icon
32
Pentair
PNR
$10.8B
$10.5M 1.27%
+217,296
New +$11.1M
PARA
33
DELISTED
Paramount Global Class B
PARA
$10.3M 1.24%
165,120
-29,600
-15% -$1.76M
ICPT
34
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$9.97M 1.21%
42,148
+26,026
+161% +$6.86M
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$124B
$9.68M 1.17%
102,203
-68,307
-40% -$4.79M
CLVS
36
DELISTED
Clovis Oncology, Inc.
CLVS
$8.73M 1.06%
210,933
+134,733
+177% +$6.94M
CL icon
37
Colgate-Palmolive
CL
$74.2B
$8.22M 0.99%
+120,522
New +$8.08M
AAL icon
38
American Airlines Group
AAL
$10.2B
$8.14M 0.98%
+189,400
New +$7.39M
TWX
39
DELISTED
Time Warner Inc
TWX
$8.11M 0.98%
+115,456
New +$7.59M
GM icon
40
General Motors
GM
$81.7B
$7.59M 0.92%
+209,200
New +$7.29M
CSCO icon
41
Cisco
CSCO
$456B
$7.54M 0.91%
303,240
+26,600
+10% +$634K
MET icon
42
MetLife
MET
$62.7B
$7.35M 0.89%
148,499
-9,313
-6% -$436K
AMZN icon
43
Amazon
AMZN
$2.48T
$7.13M 0.86%
438,840
-1,100
-0.3% -$17.4K
KO icon
44
Coca-Cola
KO
$380B
$6.81M 0.82%
160,700
LNC icon
45
Lincoln National
LNC
$8.19B
$6.7M 0.81%
130,244
-1,200
-0.9% -$59.3K
JPM icon
46
JPMorgan Chase
JPM
$950B
$6.64M 0.8%
115,260
+5,560
+5% +$313K
V icon
47
Visa
V
$697B
$6.58M 0.8%
125,008
+12,800
+11% +$669K
HPQ icon
48
HP
HPQ
$25.9B
$6.53M 0.79%
427,210
-7,707
-2% -$116K
RTX icon
49
RTX Corp
RTX
$295B
$6.53M 0.79%
89,937
-85,393
-49% -$6.29M
DHR icon
50
Danaher
DHR
$140B
$6.49M 0.78%
122,672

Similar funds

Suffolk Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Suffolk Capital Management held 168 positions worth $827M, up 2.5% from $807M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Suffolk Capital Management's Q2 2014 filing shows 33 new, 41 increased, 59 reduced and 29 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 359,700 shares worth $12.6M. The largest sale was Altera Corp, an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Suffolk Capital Management's largest Q2 2014 buy was Twenty-First Century Fox, Inc. Class A: 359,700 shares worth $12.6M.
  • Suffolk Capital Management added most to Clovis Oncology, Inc. in Q2 2014, an estimated $6.94M increase.
  • Suffolk Capital Management's biggest Q2 2014 reduction was RTX Corp, cutting an estimated $6.29M.
  • Suffolk Capital Management fully exited Altera Corp in Q2 2014, selling an estimated $12.7M.
  • Suffolk Capital Management's ten largest holdings make up 20% of its $827M portfolio in Q2 2014.
  • Suffolk Capital Management opened 33 new positions and closed 29 in Q2 2014.
  • Suffolk Capital Management's portfolio value rose 2.5% quarter-over-quarter to $827M.

Based on Suffolk Capital Management's 13F filing for Q2 2014, filed 7 Aug 2014.